跳至主要内容
临床试验/JPRN-UMIN000003237
JPRN-UMIN000003237已完成3 期

A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC) - A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)

Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 71 人开始时间: 2010年2月23日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
71

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy 2) Patients requiring the administration of phenytoin or warfarin potassium 3) Pregnant or lactating women or women of childbearing potential 4) Psychosis 5) Patients requiring systemic steroids medication 6) Serum HBs antigen positive 7) Anti-HIV antibody positive 8) Uncontrollable diabetes mellitus or administration of insulin. 9) Uncontrollable hypertention 10) Unstable angina, heart failure, or with a history of myocardial infarction within 6 months. 11) Interstitial pneumonia, fibroid lung, or severe emphysema 12) Active bacterial or fungous infection 13) fever over 38 degrees centigrade

研究者

发起方
Japan Clinical Oncology Group(JCOG)

相似试验

A phase I/II trial of chemoradiotherapy concurrent... | 临床试验